BioSpace News Archive

Drug Development

Biohaven Enrolls First Patient In Phase 3 Clinical Trial To Evaluate Rimegepant Zydis® ODT In The Acute Treatment Of Migraine

Biohaven Pharmaceutical Holding Company Ltd. announced that it has enrolled the first patient in a Phase 3 clinical trial of the Zydis® orally dissolving tablet (“ODT”) formulation of rimegepant for the acute treatment of migraine.

March 6, 2018
·
2 min read
Business

Adicet Bio Announces the Transition of Founder, President and Chief Executive Officer Dr. Aya Jakobovits

Adicet Bio, Inc. (“Adicet”), a biopharmaceutical company focused on the development of next-generation cell immunotherapies, announced today that Aya Jakobovits, Ph.D., Founder of Adicet Bio, has retired from her position as President and Chief Executive Officer.

March 6, 2018
·
2 min read
Business

QIAGEN announces 20-F annual report filing for 2017 results

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

March 6, 2018
·
3 min read
Drug Development

Apexigen and the Pediatric Brain Tumor Consortium Announce a Clinical Collaboration to Evaluate APX005M in Children with Brain Tumors

Study to evaluate the safety and tolerability of APX005M, a CD40 agonistic antibody, in pediatric patients with recurrent or refractory brain tumors

March 6, 2018
·
4 min read
Biotech Beach

Nihon Kohden Launches Award-Winning Augmented Reality App at HIMSS18

Immersive Cardiology training app enhances clinical excellence services of Nihon Kohden University.

March 6, 2018
·
4 min read
Business

Vycor Announces That it is Accelerating the Roll-out of its Enhanced VBAS due to Surgeon Feedback

Following surgeon feedback Vycor has decided that it will from now be shipping only the enhanced model VBAS across the complete main range of 12 VBAS sizes.

March 6, 2018
·
3 min read
ARANZ Medical announces issuance of new patent and 2017 closing of NZ$3million

ARANZ Medical announced today the issuance of United States Patent 9,861,285, Handheld Skin Measuring or Monitoring Device, the most recent patent to be issued in ARANZ Medical’s growing portfolio of intellectual property.

March 6, 2018
·
2 min read
Deals

DRX9000™ Intellectual Property Acquisition Finalized, Excite Medical Positioned for Growth

Included in the purchase are all applications, programs, designs, drawings, source codes, schematics, and U.S. FDA 510(k) certificates for all DRX9000™ spinal decompression devices along with four trademarks, including the “DRX®" mark.

March 6, 2018
·
2 min read
Deals

Advantum Health Acquires MedAdvantage

Expands Provider Enrollment and Credentialing services for Physicians, Hospitals, Health Systems, and Payer Organizations

March 6, 2018
·
3 min read
Biotech Bay

Amgen Announces Preliminary Results Of Tender Offer

Amgen (NASDAQ:AMGN) today announced the preliminary results of its modified Dutch auction tender offer, which expired at 12:00 Midnight, New York City time, at the end of March 5, 2018.

March 6, 2018
·
6 min read